These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 37470625)

  • 1. Rate of clinical breast cancer screening change during COVID-19 outbreak.
    Mungmunpuntipantip R; Wiwanitkit V
    J Cancer Res Ther; 2023; 19(3):844. PubMed ID: 37470625
    [No Abstract]   [Full Text] [Related]  

  • 2. Short term effects of an initial COVID-19 outbreak on breast cancer care. A brief report.
    Barco Nebreda I; García-Fernández A; Menchen Palau L; Giménez Gómez N; Fraile López-Amor M
    Cir Esp (Engl Ed); 2023 Jan; 101(1):70-72. PubMed ID: 35483584
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic.
    Zhou JZ; Kane S; Ramsey C; Akhondzadeh M; Banerjee A; Shatsky R; Gold KA
    JAMA Netw Open; 2022 Feb; 5(2):e2148581. PubMed ID: 35166787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation.
    Budukh AM; Dikshit R; Chaturvedi P
    Int J Cancer; 2021 Oct; 149(8):1619-1620. PubMed ID: 34152021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Collateral damages of the Covid-19 pandemic in breast cancer screening].
    Villaseñor-Navarro Y; Sollozo-Dupont I
    Salud Publica Mex; 2021 Jun; 63(4):461. PubMed ID: 35077083
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
    Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
    Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona.
    Zanelli S; Fiorio E; Zampiva I; Zacchi F; Borghesani G; Giontella E; Parolin V; Biondani P; Zuliani S; Dieci MV; Mioranza E; Zorzi M; Conti M; Gibellini D; Verlato G; Milella M
    Ann Oncol; 2022 Jun; 33(6):661-663. PubMed ID: 35276335
    [No Abstract]   [Full Text] [Related]  

  • 8. Redressing breast cancer screening disparities during the COVID-19 pandemic: Turning crisis into opportunity.
    Fieber JH; Fayanju OM
    Am J Surg; 2022 Oct; 224(4):1038. PubMed ID: 35637021
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan.
    Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM
    Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.
    Toss A; Lambertini M; Punie K; Grandi G; Cortesi L
    Int J Cancer; 2020 Dec; 147(12):3574-3575. PubMed ID: 32557656
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan.
    Chou CP; Pan HB; Yang TL; Chiang CL; Huang JS; Tsai MY
    Breast J; 2021 Jan; 27(1):89-91. PubMed ID: 32815587
    [No Abstract]   [Full Text] [Related]  

  • 13. The Other Cost of the Pandemic.
    Obispo B; Rogado J; Lara Álvarez MÁ
    Clin Breast Cancer; 2022 Jan; 22(1):e108. PubMed ID: 34176733
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
    Tomasik B; Braun M
    ESMO Open; 2021 Jun; 6(3):100108. PubMed ID: 33862335
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing the Risk of Delayed Breast Cancer Screening Versus COVID-19 Vaccination Associated Axillary Lymphadenopathy.
    Garver K
    Acad Radiol; 2021 Sep; 28(9):1198-1199. PubMed ID: 34400078
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to: COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?
    Toss A
    ESMO Open; 2021 Jun; 6(3):100109. PubMed ID: 33845361
    [No Abstract]   [Full Text] [Related]  

  • 17. Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
    Vanni G; Pellicciaro M; Materazzo M; Bruno V; Oldani C; Pistolese CA; Buonomo C; Caspi J; Gualtieri P; Chiaravalloti A; Palombi L; Piccione E; Buonomo OC
    In Vivo; 2020; 34(5):3047-3053. PubMed ID: 32871851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ten hot issues on diagnosis and treatment of breast cancer under the outbreak of novel coronavirus pneumonia].
    Jiang ZF; Li JB
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):721-723. PubMed ID: 32192284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.